|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.160 EUR | -0.43% |
|
+0.43% | -21.09% |
| 29/06 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
| 22/06 | Erfo Keeps Buying Back Stock, Repurchases 28,000 Shares | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 39.47L | 47.41L | 46.21L | 78.61L |
Direct | 6L | 5L | 7L | 9L | 10.88L |
Other | - | 5L | 6L | 6L | 7L |
Medical | - | 1L | 2L | 3L | 4L |
Revenues from Services | 1.12T | - | - | - | - |
Wholesale Sales Revenues | 40.72L | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 46.63L | 50.13L | 52.28L | 53.29L | 89.59L |
France | - | - | 8L | 9L | 9L |
Belgium | - | - | 2L | 2L | 2L |
Other (EU) | - | - | 5T | - | - |
Spain | 8T | 15.4T | 5.17T | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.43% | +0.43% | -11.45% | +8.41% | 1.14Cr | ||
| +1.86% | +7.65% | +55.77% | +158.84% | 1,08200Cr | ||
| +3.57% | +7.42% | +69.09% | +58.92% | 63TCr | ||
| +3.99% | +7.37% | +36.87% | +93.77% | 46TCr | ||
| +3.41% | -1.94% | +26.41% | +20.22% | 34TCr | ||
| -0.23% | +1.45% | +42.36% | +40.02% | 30TCr | ||
| +0.09% | +1.27% | +32.11% | +44.43% | 29TCr | ||
| -1.05% | +3.02% | -25.20% | -39.49% | 23TCr | ||
| +3.55% | +6.05% | +26.04% | +68.52% | 20TCr | ||
| +4.21% | +6.00% | +17.72% | +70.33% | 16TCr | ||
| Average | +1.42% | +4.24% | +26.97% | +52.40% | 37TCr | |
| Weighted average by Cap. | +1.46% | +5.21% | +41.82% | +81.31% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















